EbolaRick Sacra

Treated with TKM-Ebola

23 Sep, 2014

Doctors at the Nebraska Medical Centre biocontainment unit say Sacra has been treated with the experimental TKM-Ebola, manufactured by Canadian company Tekmira, which is designed to stop the virus replicating. Doctors had previously declined to identify the drug. Dr. Angela Hewett:

We don’t know if it was Dr. Sacra’s own immune system, the supportive therapy we provided, the blood transfusion from Dr. Brantly, TKM-Ebola or a combination of all these factors that helped Dr. Sacra recover

Add your comments below...